Retraction: HLA-B35 upregulates endothelin-1 and downregulates endothelial nitric oxide synthase via endoplasmic reticulum stress response in endothelial cells (Journal of Immunology (2010) 184 (4654-4661) DOI: 10.4049/jimmunol.0903188);HLA-B35 upregulates endothelin-1 and downregulates endothelial nitric oxide synthase via endoplasmic reticulum stress response in endothelial cells

Journal of Immunology

Volumn 184, Issue 9, 2010, Pages 4654-4661

  Lenna, Stefania ^a   Townsend, Danyelle M ^b   Tan, Filemon K ^c   Kapanadze, Bagrat ^b   Markiewicz, Malgorzata ^b   Trojanowska, Maria ^a   Scorzax, Raffaella ^d  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 70; HLA B35 ANTIGEN; MESSENGER RNA; THAPSIGARGIN;

ARTICLE; CYTOKINE PRODUCTION; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LEUKOCYTE; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; CELL CULTURE; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; ENDOPLASMIC RETICULUM; ENZYMOLOGY; IMMUNOLOGY; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

CELL LINE; CELLS, CULTURED; DOWN-REGULATION; ENDOPLASMIC RETICULUM; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; HLA-B35 ANTIGEN; HUMANS; HYPERTENSION, PULMONARY; NITRIC OXIDE SYNTHASE TYPE III; STRESS, PHYSIOLOGICAL; UP-REGULATION;

EID: 77954523038     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.2100171     Document Type: Erratum

References (62)

1. Parham, P., C. E. Lomen, D. A. Lawlor, J. P. Ways, N. Holmes, H. L. Coppin, R. D. Salter, A. M. Wan, and P. D. Ennis. 1988. Nature of polymorphism in HLA-A, -B, and -C molecules. Proc. Natl. Acad. Sci. USA 85: 4005-4009.
2. Itescu, S., S. Rose, E. Dwyer, and R. Winchester. 1995. Grouping HLA-B locus serologic specificities according to shared structural motifs suggests that different peptide-anchoring pockets may have contrasting influences on the course of HIV-1 infection. Hum. Immunol. 42: 81-89.
3. Fiorillo, M. T., M. Maragno, R. Butler, M. L. Dupuis, and R. Sorrentino. 2000. CD8(+) T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis. J. Clin. Invest. 106: 47-53.
4. Johnson, R. P., A. Trocha, T. M. Buchanan, and B. D. Walker. 1993. Recognition of a highly conserved region of human immunodeficiency virus type 1 gp120 by an HLA-Cw4-restricted cytotoxic T-lymphocyte clone. J. Virol. 67: 438-445.
5. Rowland-Jones, S., T. Dong, P. Krausa, J. Sutton, H. Newell, K. Ariyoshi, F. Gotch, S. Sabally, T. Corrah, J. Kimani, et al. 1998. The role of cytotoxic T-cells in HIV infection. Dev. Biol. Stand. 92: 209-214.
6. McAdam, S., P. Klenerman, L. Tussey, S. Rowland-Jones, D. Lalloo, R. Phillips, A. Edwards, P. Giangrande, A. L. Brown, F. Gotch, et al. 1995. Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses. J. Immunol. 155: 2729-2736.
7. Shiga, H., T. Shioda, H. Tomiyama, Y. Takamiya, S. Oka, S. Kimura, Y. Yamaguchi, T. Gojoubori, H. G. Rammensee, K. Miwa, and M. Takiguchi. 1996. Identification of multiple HIV-1 cytotoxic T-cell epitopes presented by human leukocyte antigen B35 molecules. AIDS 10: 1075-1083. (Pubitemid 26283344)
8. Tomiyama, H., K. Miwa, H. Shiga, Y. I. Moore, S. Oka, A. Iwamoto, Y. Kaneko, and M. Takiguchi. 1997. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-Bp3501 molecules that are associated with the accelerated progression of AIDS. J. Immunol. 158: 5026-5034. (Pubitemid 127483829)
9. Hill, A. V., C. E. Allsopp, D. Kwiatkowski, N. M. Anstey, P. Twumasi, P. A. Rowe, S. Bennett, D. Brewster, A. J. McMichael, and B. M. Greenwood. 1991. Common west African HLA antigens are associated with protection from severe malaria. Nature 352: 595-600.
10. Pettersen, R. D., G. Gaudernack, M. K. Olafsen, S. O. Lie, and K. Hestdal. 1998. The TCR-binding region of the HLA class I alpha2 domain signals rapid Fasindependent cell death: a direct pathway for T cell-mediated killing of target cells? J. Immunol. 160: 4343-4352.
11. Salazar, G., G. Colombo, S. Lenna, R. Antonioli, L. Beretta, A. Santaniello, and R. Scorza. 2007. HLA-B35 influences the apoptosis rate in human peripheral blood mononucleated cells and HLA-transfected cells. Hum. Immunol. 68: 181-191.
12. Tscherning, T., and M. H. Claësson. 1994. Signal transduction via MHC class-I molecules in T cells. Scand. J. Immunol. 39: 117-121.
13. Bian, H., P. E. Harris, A. Mulder, and E. F. Reed. 1997. Anti-HLA antibody ligation to HLA class I molecules expressed by endothelial cells stimulates tyrosine phosphorylation, inositol phosphate generation, and proliferation. Hum. Immunol. 53: 90-97.
14. Daniel, D., G. Opelz, A. Mulder, C. Kleist, and C. Süsal. 2004. Pathway of apoptosis induced in Jurkat T lymphoblasts by anti-HLA class I antibodies. Hum. Immunol. 65: 189-199.
15. Daniel, D., G. Opelz, A. Mulder, and C. Süsal. 2003. Induction of apoptosis in human lymphocytes by human anti-HLA class I antibodies. Transplantation 75: 1380-1386. (Pubitemid 36513052)
16. Genestier, L., G. Meffre, P. Garrone, J. J. Pin, Y. J. Liu, J. Banchereau, and J. P. Revillard. 1997. Antibodies to HLA class I alpha1 domain trigger apoptosis of CD40-activated human B lymphocytes. Blood 90: 726-735. (Pubitemid 27299113)
17. Genestier, L., R. Paillot, N. Bonnefoy-Berard, G. Meffre, M. Flacher, D. Fèvre, Y. J. Liu, P. Le Bouteiller, H.Waldmann, V. H. Engelhard, et al. 1997. Fas-independent apoptosis of activated T cells induced by antibodies to the HLA class I alpha1 domain. Blood 90: 3629-3639. (Pubitemid 27473433)
18. Genestier, L., A. F. Prigent, R. Paillot, L. Quemeneur, I. Durand, J. Banchereau, J. P. Revillard, and N. Bonnefoy-Bérard. 1998. Caspase-dependent ceramide production in Fas- and HLA class I-mediated peripheral T cell apoptosis. J. Biol. Chem. 273: 5060-5066.
19. Henrotte, J. G. 1980. The variability of human red blood cell magnesium level according to HLA groups. Tissue Antigens 15: 419-430.
20. Edidin, M. 1988. Function by association? MHC antigens and membrane receptor complexes. Immunol. Today 9: 218-219.
21. Ollier,W., T. Spector, A. Silman, L. Perry, J. Ord,W. Thomson, and H. Festenstein. 1989. Are certain HLA haplotypes responsible for low testosterone levels in males? Dis. Markers 7: 139-143.
22. Reiland, J., and M. Edidin. 1993. Chemical cross-linking detects association of insulin receptors with four different class I human leukocyte antigen molecules on cell surfaces. Diabetes 42: 619-625. (Pubitemid 23097196)
23. Frauman, A. G., P. Chu, and L. C. Harrison. 1993. Nonimmune thyroid destruction results from transgenic overexpression of an allogeneic major histocompatibility complex class I protein. Mol. Cell. Biol. 13: 1554-1564.
24. Scorza Smeraldi, R., G. Fabio, A. Lazzarin, N. B. Eisera, M. Moroni, and C. Zanussi; ScorzaSmeraldi. 1986. HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human-immunodeficiency-virus infection. Lancet 2: 1187-1189.
25. Scorza Smeraldi, R., G. Fabio, A. Lazzarin, N. Eisera, C. Uberti Foppa, M. Moroni, and C. Zanussi; ScorzaSmeraldi. 1988. HLA-associated susceptibility to AIDS: HLA B35 is a major risk factor for Italian HIV-infected intravenous drug addicts. Hum. Immunol. 22: 73-79.
26. Itescu, S., U. Mathur-Wagh, M. L. Skovron, L. J. Brancato, M. Marmor, A. Zeleniuch-Jacquotte, and R. Winchester. 1992. HLA-B35 is associated with accelerated progression to AIDS. J. Acquir. Immune Defic. Syndr. 5: 37-45.
27. Kaplan, C., J. Y. Muller, C. Doinel, J. J. Lefrère, F. Paquez, P. Rouger, D. Salmon, and C. Salmon. 1990. HLA-associated susceptibility to acquired immune deficiency syndrome in HIV-1-seropositive subjects. Hum. Hered. 40: 290-298.
28. Carrington, M., G. W. Nelson, M. P. Martin, T. Kissner, D. Vlahov, J. J. Goedert, R. Kaslow, S. Buchbinder, K. Hoots, and S. J. O'Brien. 1999. HLA and HIV-1: heterozygote advantage and Bp35-Cwp04 disadvantage. Science. 283: 1748-1752. (Pubitemid 129502065)
29. Gobin, S. J., M. van Zutphen, A. M. Woltman, and P. J. van den Elsen. 1999. Transactivation of classical and nonclassical HLA class I genes through the IFN-stimulated response element. J. Immunol. 163: 1428-1434.
30. Santaniello, A., G. Salazar, S. Lenna, R. Antonioli, G. Colombo, L. Beretta, and R. Scorza. 2006. HLA-B35 upregulates the production of endothelin-1 in HLA-transfected cells: a possible pathogenetic role in pulmonary hypertension. Tissue Antigens 68: 239-244. (Pubitemid 44341798)
31. Grigolo, B., I. Mazzetti, R. Meliconi, S. Bazzi, R. Scorza, M. Candela, A. Gabrielli, and A. Facchini. 2000. Anti-topoisomerase II alpha autoantibodies in systemic sclerosis-association with pulmonary hypertension and HLA-B35. Clin. Exp. Immunol. 121: 539-543.
32. Scorza, R., M. Caronni, S. Bazzi, F. Nador, L. Beretta, R. Antonioli, L. Origgi, A. Ponti, M. Marchini, and M. Vanoli. 2002. Post-menopause is the main risk factor for developing isolated pulmonary hypertension in systemic sclerosis. Ann. N. Y. Acad. Sci. 966: 238-246.
33. Humbert, M., D. Montani, F. Perros, P. Dorfmüller, S. Adnot, and S. Eddahibi. 2008. Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension. Vascul. Pharmacol. 49: 113-118.
34. Granton, J. T., and M. Rabinovitch. 2002. Pulmonary arterial hypertension in congenital heart disease. Cardiol. Clin. 20: 441-457, vii (vii.).
35. Gaine, S. P., and L. J. Rubin. 1998. Primary pulmonary hypertension. Lancet 352: 719-725.
36. Stewart, D. J., R. D. Levy, P. Cernacek, and D. Langleben. 1991. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann. Intern. Med. 114: 464-469.
37. Vancheeswaran, R., T. Magoulas, G. Efrat, C. Wheeler-Jones, I. Olsen, R. Penny, and C. M. Black. 1994. Circulating endothelin-1 levels in systemic sclerosis subsets -a marker of fibrosis or vascular dysfunction? J. Rheumatol. 21: 1838-1844.
38. Coggins, M. P., and K. D. Bloch. 2007. Nitric oxide in the pulmonary vasculature. Arterioscler. Thromb. Vasc. Biol. 27: 1877-1885.
39. Braun-Moscovici, Y., A. M. Nahir, and A. Balbir-Gurman. 2004. Endothelin and pulmonary arterial hypertension. Semin. Arthritis Rheum. 34: 442-453.
40. Ramirez, A., and J. Varga. 2004. Pulmonary arterial hypertension in systemic sclerosis: clinical manifestations, pathophysiology, evaluation, and management. Treat. Respir. Med. 3: 339-352.
41. Yoshibayashi, M., K. Nishioka, K. Nakao, Y. Saito, M. Matsumura, T. Ueda, S. Temma, G. Shirakami, H. Imura, and H. Mikawa. 1991. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation. Circulation 84: 2280-2285.
42. Galié, N., A. Manes, and A. Branzi. 2004. The endothelin system in pulmonary arterial hypertension. Cardiovasc. Res. 61: 227-237.
43. He, T. C., S. Zhou., L. T. da Costa, J. Yu, K. W. Kinzler, and B. Vogelstein. 1988. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95: 2509-2514.
44. Laufen, T., M. P. Mayer, C. Beisel, D. Klostermeier, A. Mogk, J. Reinstein, and B. Bukau. 1999. Mechanism of regulation of hsp70 chaperones by DnaJ cochaperones. Proc. Natl. Acad. Sci. USA 96: 5452-5457.
45. Walsh, P., D. Bursać, Y. C. Law, D. Cyr, and T. Lithgow. 2004. The J-protein family: modulating protein assembly, disassembly and translocation. EMBO Rep. 5: 567-571.
46. Qiu, X. B., Y. M. Shao, S. Miao, and L. Wang. 2006. The diversity of the DnaJ/ Hsp40 family, the crucial partners for Hsp70 chaperones. Cell. Mol. Life Sci. 63: 2560-2570.
47. Daugaard, M., M. Rohde, and M. Jäättelä. 2007. The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions. FEBS Lett. 581: 3702-3710.
48. Kleizen, B., and I. Braakman. 2004. Protein folding and quality control in the endoplasmic reticulum. Curr. Opin. Cell Biol. 16: 343-349.
49. Marciniak, S. J., and D. Ron. 2006. Endoplasmic reticulum stress signaling in disease. Physiol. Rev. 86: 1133-1149.
50. Wu, J., and R. J. Kaufman. 2006. From acute ER stress to physiological roles of the Unfolded Protein Response. Cell Death Differ. 13: 374-384.
51. Shen, X., K. Zhang, and R. J. Kaufman. 2004. The unfolded protein response - a stress signaling pathway of the endoplasmic reticulum. J. Chem. Neuroanat. 28: 79-92.
52. Schröder, M. 2008. Endoplasmic reticulum stress responses. Cell. Mol. Life Sci. 65: 862-894.
53. Kim, I., W. Xu, and J. C. Reed. 2008. Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat. Rev. Drug Discov. 7: 1013-1030.
54. Sevier, C. S., and C. A. Kaiser. 2008. Ero1 and redox homeostasis in the endoplasmic reticulum. Biochim. Biophys. Acta. 1783: 549-556.
55. Dakwar, E., J. Reddy, F. L. Vale, and J. S. Uribe. 2008. A review of the pathogenesis of ankylosing spondylitis. Neurosurg. Focus 24: E2.
56. Colbert, R. A., M. L. DeLay, G. Layh-Schmitt, and D. P. Sowders. 2009. HLA-B27 misfolding and spondyloarthropathies. Prion 3: 15-26.
57. Tran, T. M., N. Satumtira, M. L. Dorris, E. May, A. Wang, E. Furuta, and J. D. Taurog. 2004. HLA-B27 in transgenic rats forms disulfide-linked heavy chain oligomers and multimers that bind to the chaperone BiP. J. Immunol. 172: 5110-5119.
58. Turner, M. J., D. P. Sowders, M. L. DeLay, R. Mohapatra, S. Bai, J. A. Smith, J. R. Brandewie, J. D. Taurog, and R. A. Colbert. 2005. HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response. J. Immunol. 175: 2438-2448.
59. Turner, M. J., M. L. Delay, S. Bai, E. Klenk, and R. A. Colbert. 2007. HLA-B27 up-regulation causes accumulation of misfolded heavy chains and correlates with the magnitude of the unfolded protein response in transgenic rats: Implications for the pathogenesis of spondylarthritis-like disease. Arthritis Rheum. 56: 215-223.
60. Taurog, J. D., S. D. Maika, N. Satumtira, M. L. Dorris, I. L. McLean, H. Yanagisawa, A. Sayad, A. J. Stagg, G. M. Fox, A. Lê O'Brien, et al. 1999. Inflammatory disease in HLA-B27 transgenic rats. Immunol. Rev. 169: 209-223.
61. Colbert, R. A. 2004. The immunobiology of HLA-B27: variations on a theme. Curr. Mol. Med. 4: 21-30.
62. Gargalovic, P. S., N. M. Gharavi, M. J. Clark, J. Pagnon, W. P. Yang, A. He, A. Truong, T. Baruch-Oren, J. A. Berliner, T. G. Kirchgessner, and A. J. Lusis. 2006. The unfolded protein response is an important regulator of inflammatory genes in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 26: 2490-2496.